Sign in / Join Now
ETFs & Funds
- every investor should consider it
Agree added today @$43.50 before the FDA announcement. It also has big upside in Asia:
Thanks Mercy. Part of the global deleveraging has to be government support for generic drug manufacturers. The consumer only benefits.
Add a reply...
Latest StockTalks »
people get TEVA breaking news and analysis by email alert.
Get email alerts on TEVA »
Teva Pharmaceutical Industries Limited
Get latest price
From other sites
Teva Receives Positive Outcome For COPAXONE® Label In Europe
at TheStreet (Tue, 2:00AM)
Teva Shares Drop Following Guidance Update
at Benzinga (Mon, 5:14PM)
Teva Appoints Dipankar Bhattacharjee As President And Chief Executive Officer, Global Generic Medicines Group, Succeeding Siggi Olafsson
at TheStreet (Mon, 4:01PM)
TEVA SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds INSTITUTIONAL Investors With Losses In Excess Of $500,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Teva Pharmaceutical Industries Limited - TEVA
at TheStreet (Fri, 10:07PM)
Teva Pharmaceutical Industries Limited (TEVA) Ex-Dividend Date Scheduled for December 01, 2016
at Nasdaq.com (Wed, 9:00AM)